Announcements Trials
Browse Landscape

Phase

Phase 2 233Phase 3 150Phase 1 108Phase 1/2 54Phase 2/3 12Phase NA 11Phase EARLY_PHASE1 5Phase 4 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 11Thoracic 5Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1

Conditions

Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10human papillomavirus vaccine, L1 type 16, 18 7olaparib 4niraparib 4Human Papillomavirus Recombinant Vaccine nonavalent 4Vaccines 3Saline Solution 3Papillomavirus Vaccines 3Medroxyprogesterone Acetate 3Carboplatin 3Bevacizumab 3pegylated granulocyte colony-stimulating factor 2liposomal doxorubicin 2fluciclovine F-18 2apatinib 2Sevoflurane 2Propofol 2Paclitaxel 2Aspirin 2semaglutide 1pegfilgrastim 1pazopanib 1palbociclib 1lenvatinib 1halofantrine 1ganirelix 1gadofosveset trisodium 1fosaprepitant 1follicle stimulating hormone, human, with HCG C-terminal peptide 1ferrous gluconate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Paclitaxel × Gynecologic × Clear all
NCT01706120 2023-03-24

MITO16/MANGO-2

National Cancer Institute, Naples

Phase 4 Unknown
400 enrolled
Gynecologic

Ovarian Neoplasms

NCT03794778 2022-07-18

Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase 4 Unknown
396 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡